Saltroad raised 1.5 million GBP and acquired Ogma, an AI documentation platform designed for speech and language therapy. The round was led by Techstart Ventures, with participation from Ascension, ScaleX and angel investors. The funding and acquisition will support scaling Saltroad's therapist network and embedding AI tooling to automate clinical notes and reduce administrative burden.
About Saltroad
Saltroad is a clinician-led speech and language therapy provider that gives families private access to NHS speech and language therapists and uses AI to automate clinical notes while keeping clinicians at the centre of care.
Northern Ireland, United Kingdom
Read Company ProfileFrequently Asked Questions
What type of funding round did Saltroad raise?
Saltroad raised a unspecified round.
How much did Saltroad raise in its unspecified?
Saltroad raised $1,500,000 GBP in its unspecified.
When did Saltroad raise its unspecified?
Saltroad raised its unspecified on 2026-06-30.
Who invested in Saltroad's unspecified?
The investors in Saltroad's unspecified are: Techstart Ventures, Ascension, ScaleX, group of prominent angel investors.
What type of investment was Saltroad's unspecified?
Saltroad's unspecified was a equity investment.
How will Saltroad use the funds from its unspecified?
Saltroad plans to use the funds for: scale its nationwide network of therapists, use AI to automate clinical notes, build an AI-enabled speech and language therapy workforce, free therapists to spend more time with children and less on admin.